Company news
Sophiris Bio Inc news in 2013
Sophiris Bio Inc's news releases, calls and decks from 2013, newest first.
Sophiris Bio Reports Third Quarter Financial Results and Recent Key Operational Highlights
November 12, 2013
Sophiris Bio Applies for Voluntary Delisting from TSX
November 5, 2013
Sophiris Announces First Patients Dosed in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia
October 28, 2013
Sophiris Bio to Present at the Stifel Healthcare Conference
September 5, 2013
Sophiris Bio Closes $65 Million Public Offering
August 23, 2013
Sophiris Bio Prices its Previously Announced Public Offering of Common Shares
August 16, 2013
Sophiris Bio Announces Share Consolidation
August 12, 2013
Sophiris Bio Reports Second Quarter Financial Results and Recent Key Operational Highlights
August 5, 2013
Sophiris Bio Announces an Addition to its Board of Directors
July 15, 2013
Sophiris Bio Announces Changes to Board of Directors
July 12, 2013
Sophiris Bio Inc. Announces Election of Directors
June 14, 2013
Sophiris Bio Reports First Quarter Financial Results and Recent Key Operational Highlights
April 30, 2013
Correction - Sophiris Bio Inc. Files Registration Statement for Proposed Initial U.S. Public Offering on the NASDAQ
February 18, 2013
Sophiris Bio Inc. Files Registration Statement for Proposed Initial U.S. Public Offering on the NASDAQ
February 15, 2013
Sophiris Bio Reports Fourth Quarter and Year-End 2012 Financial Results and Key Operational Highlights
February 13, 2013